Renal Anhydramnios Fetal Therapy | stella

Learn Find trials matched to me

Learn Find trials matched to me →

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Privacy For Researchers Data Labs ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Renal Anhydramnios Fetal Therapy | stella

Back to Anhydramnios trials

Completed

Plain-English translation of NCT03101891 on ClinicalTrials.gov ↗ ·

· Source last updated July 2026

How we translate trials

Read our Kidney disease research guide →

Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.

Trial locations(9 sites)

United States

University of Southern California/Children's Hospital of Los Angeles/Huntington Hospital, Los Angeles, California

University of California San Francisco, San Francisco, California

Stanford University, Stanford, California

University of Colorado Denver, Aurora, Colorado

Johns Hopkins Hospital, Baltimore, Maryland

Results

Read the full plain-English summary of this trial →

Key details

Phase

Safety & dosing

Sponsor

Johns Hopkins University

Collaborators

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Enrollment target

~55 participants

Started

December 2018

Primary completion

March 2025

Age range

18 Years and older

Sex

Female only

Last updated on clinicaltrials.gov in July 2026.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov